Analyst Ratings for Acadia Pharmaceuticals (ACAD)
ACAD Rating Summary
ACAD Price Target Summary
- Highest: $70.00 (Cantor Fitzgerald)
- Lowest: $18.00 (H.C. Wainwright)
- Average: $33.25
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$33.25 (+57.2%)
* Over Last 12-Mos
Rating Score: 4.3 / 10
Percentile Rank: 41%
Avg. $ Target:
$33.25 (+57.2%)
* Over Last 12-Mos
Rating Score: 4.3 / 10
Percentile Rank: 41%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/7/2021 | H.C. Wainwright | Andrew S. Fein | Downgrade | Neutral (Buy) |
18.00 (43.00) |
20.64 (21.15) |
2.47% | Details |
| 4/6/2021 | Canaccord Genuity | Sumant Kulkami | Downgrade | Hold (Buy) |
26.00 (N/A) |
21.18 (21.15) |
-0.14% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
